C4 Therapeutics (CCCC) Asset Utilization Ratio (2020 - 2025)
C4 Therapeutics (CCCC) has 6 years of Asset Utilization Ratio data on record, last reported at 0.12 in Q4 2025.
- For Q4 2025, Asset Utilization Ratio rose 17.37% year-over-year to 0.12; the TTM value through Dec 2025 reached 0.12, up 17.37%, while the annual FY2025 figure was 0.1, 3.5% up from the prior year.
- Asset Utilization Ratio reached 0.12 in Q4 2025 per CCCC's latest filing, up from 0.11 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.12 in Q1 2025 and bottomed at 0.04 in Q2 2023.
- Average Asset Utilization Ratio over 5 years is 0.08, with a median of 0.09 recorded in 2021.
- Peak YoY movement for Asset Utilization Ratio: plummeted 58.14% in 2023, then soared 129.92% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.09 in 2021, then dropped by 22.77% to 0.07 in 2022, then fell by 16.05% to 0.06 in 2023, then soared by 67.61% to 0.1 in 2024, then rose by 17.37% to 0.12 in 2025.
- Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.12 in Q4 2025, 0.11 in Q3 2025, and 0.11 in Q2 2025.